4.4 Article

Chinese Cases of Metachromatic Leukodystrophy with the Novel Missense Mutations in ARSA Gene

Journal

JOURNAL OF MOLECULAR NEUROSCIENCE
Volume 71, Issue 2, Pages 245-251

Publisher

SPRINGERNATURE
DOI: 10.1007/s12031-020-01643-3

Keywords

Metachromatic leukodystrophy (MLD); Arylsulfatase A (ARSA); Mutation

Funding

  1. National Nature Science Foundation of China [81871246]
  2. KangsoMedical Inspection (Beijing, China)

Ask authors/readers for more resources

Metachromatic leukodystrophy is a neurodegenerative disorder caused by mutations in the ARSA gene, leading to deficiency of the ARSA enzyme. Common clinical features include abnormal gait and neurological symptoms. Studying novel ARSA gene mutations can provide further insights into the pathogenesis of Metachromatic leukodystrophy.
Metachromatic leukodystrophy(MLD) is an autosomal recessive hereditary neurodegenerative lysosomal storage disorder caused by the mutations in arylsulfatase A gene (ARSA), which results in the deficiency of ARSA enzyme. The common clinical characteristics of MLD are abnormal gait, and then gradually appears ataxia, spastic quadriplegia, optic atrophy, cortical blindness, and dementia. We describe two patients in China who were diagnosed with MLD and find that the four ARSA gene mutations (c.1115G>A, c.302G>T, c.893 G> T, and c.302G>T) are associated with MLD, in which c.893 G>T and c.302G>T are novel mutations by gene sequence and clinical manifestations, to further understand the relationship between MLD and ARSA gene.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available